RPCONE
CODX

Retirement Planning Company of New England’s Co-Diagnostics CODX Stock Holding History

Retirement Planning Company of New England’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-17
Closed -$4K – 338
2021
Q4 		$4K Buy
+17
New +$4.46K ﹤0.01% 770

Other funds holding CODX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ARC
Advisor Resource Council Dallas, Texas $355M AUM 30.05% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
EIP
Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return

Retirement Planning Company of New England's CODX Position: Q1 2022 in Review

Retirement Planning Company of New England sold out of Co-Diagnostics (CODX) in Q1 2022, closing a stake of 17 shares — an estimated $4K sold.

Retirement Planning Company of New England first reported a position in CODX in Q4 2021 and held it in 1 quarter. The position peaked at $4K in Q4 2021. 82 funds tracked by Wall St. Rank hold CODX as of Q1 2022.

  • Retirement Planning Company of New England reported no remaining Co-Diagnostics position as of Q1 2022 after selling out during the quarter.
  • Retirement Planning Company of New England sold 17 Co-Diagnostics shares in Q1 2022, an estimated $4K.
  • Retirement Planning Company of New England first reported a position in Co-Diagnostics in Q4 2021 and held it in 1 quarter.
  • Retirement Planning Company of New England's Co-Diagnostics position peaked at $4K in Q4 2021.
  • 82 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2022.

Based on Retirement Planning Company of New England's 13F filing for Q1 2022, filed 6 May 2022.